Solana Life Sciences Private Limited

Solana Life Sciences Private Limited - pharma in Dhar, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24231MP1999PTC013742 Incorporated 13 September 1999 ROC Gwalior HQ Dhar, Madhya Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹16.49 Cr
▲ 18% YoY
Net profit · FY 2024
₹10.43 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹1.58 Cr
EBITDA margin 9.6%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.53 Cr
Issued & subscribed
Open charges
₹23.84 Cr
Satisfied ₹11.61 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
27
Provident fund records

About Solana Life Sciences Private Limited

Data last updated:

Solana Life Sciences Private Limited is a private limited company based in Dhar, Madhya Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 13 September 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24231MP1999PTC013742. Its GSTIN is 23AAECA5202F1ZE (Madhya Pradesh).

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.53 Cr. It was formerly known as Panakeia Drugs and Intermediates Private Limited and Amir Chem Private Limited. It is led by directors Arun Durgaprasad Joshi and Yash Arun Joshi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 41 & 42 Sector – III Pithampur Industrial Area, Dhar, Madhya Pradesh, India – 454775.

As per the financials filed for FY 2024, the company reported a revenue of ₹16.49 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹10.43 Lakh (net margin 0.6%) and EBITDA of ₹1.58 Cr (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 242% over five years.

The company has about 27 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹23.84 Cr and satisfied charges of ₹11.61 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solanalifesciences.com.

Company Details of Solana Life Sciences Private Limited
CIN U24231MP1999PTC013742
Registration Number 013742
Incorporation Date 13 September 1999
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. 41 & 42 Sector – III Pithampur Industrial Area, Dhar, Madhya Pradesh, India – 454775
  • Industry
    Pharma, API Manufacturers
Comprehensive company report
Solana Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Solana Life Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Solana Life Sciences Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Solana Life Sciences Private Limited

The main business activity of Solana Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Solana Life Sciences Private Limited FY 2025 filings available

Solana Life Sciences Private Limited reported revenue of ₹16.49 Cr (up 18% YoY) for FY 2024.

Revenue · FY 2024
₹16.49 Cr ▲ 18%
Net profit · FY 2024
₹10.43 Lakh margin 0.6%
EBITDA · FY 2024
₹1.58 Cr margin 9.6%

Compounded Annual Growth Rate (CAGR) of Solana Life Sciences Private Limited

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 26%
5 years · compounded
▲ 242%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 74%
5 years · compounded
▲ 53%

Revenue has grown at a compounded annual rate (CAGR) of 242% over five years, including 18% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Solana Life Sciences Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.58 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹10.43 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Solana Life Sciences Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.6%••••••••••••••••
Net Profit Margin0.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Solana Life Sciences are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Solana Life Sciences Private Limited

Solana Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Its own revenue is ₹16.49 Cr.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Arkgen Pharma Private Limited₹16.92 Cr₹3.26 Cr19%-3%16Bangalore, Karnataka, India
MNR Labs Private Limited₹16.89 Cr₹22.85 Lakh1%-44%Hyderabad, Telangana, India
Susaah Laboratories Private Limited₹16.82 Cr₹13.13 Lakh1%-49%Secunderabad, Telangana, India
Sai Sreyas Pharmaceutical Private Limited₹16.62 Cr₹12.12 Cr-73%+27%Hyderabad, Telangana, India
Rchem Organics (Bangalore) Private Limited₹16.49 Cr₹56.98 Lakh3%+47%Bangalore, Karnataka, India
Solana Life Sciences Private Limited this company₹16.49 Cr₹10.43 Lakh0.6%Dhar, Madhya Pradesh, India
M.N.Chemicals Limited₹16.13 Cr₹33.97 Lakh2%+23%Bangalore, Karnataka, India
Palam Pharma Private Limited₹16.11 Cr₹2.06 Cr13%+9%Ahmedabad, Gujarat, India
Cornileus Pharmaceuticals Private Limited₹16.06 Cr₹55.92 Lakh3%-60%99Hyderabad, Telangana, India
Shilpa Chemspec International Private Limited₹15.42 Cr₹15.75 Lakh1%+27%Mumbai, Maharashtra, India
Gomti Research and Pharmachem Private Limited₹15.27 Cr₹43.87 Lakh3%+16%Bangalore, Karnataka, India

Peers are the five companies nearest above and the five nearest below Solana Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Figures are as filed with the Ministry of Corporate Affairs or the stock exchanges.

Auditor Details of Solana Life Sciences Private Limited

Solana Life Sciences Private Limited is audited by MANISH MATHUR for the financial year 2023.

NameStatusAppointment DateCessation Date
MANISH MATHURLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Solana Life Sciences Private Limited

Solana Life Sciences has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun Durgaprasad JoshiDirector26 Jun 20197 Years 3 MonthsCurrent
Yash Arun JoshiDirector26 Jun 20197 Years 3 MonthsCurrent

Ownership and Shareholding of Solana Life Sciences Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Solana Life Sciences Private Limited

Open charges
₹23.84 Cr
Satisfied charges
₹11.61 Cr
Breakdown by lending institutions
Axis Bank Limited₹19.65 Cr
Others₹4.19 Cr
Latest charge details
DateLenderAmountStatus
22 May 2025Others₹4.19 CrOpen
19 Oct 2022Axis Bank Limited₹5.62 CrOpen
29 Sep 2022Axis Bank Limited₹5.62 CrOpen
30 Jul 2021Axis Bank Limited₹8.41 CrOpen
03 Dec 2020Others₹37.03 LakhSatisfied

Total charge records: 12 View all charges

Employees and EPFO Compliance at Solana Life Sciences Private Limited

Solana Life Sciences Private Limited has a workforce of 27 employees as of Apr 08, 2024.

Employee count
27
Active EPFO establishments
1
Employee growth
-6.9%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Name History of Solana Life Sciences Private Limited

Solana Life Sciences has undergone 4 name changes throughout its history. The current legal name is Solana Life Sciences Private Limited.

Company NameStatus
Solana Life Sciences Private LimitedCurrent
Panakeia Drugs And Intermediates Private LimitedPrevious
Amir Chem Private LimitedPrevious
Kyros Drugs And Pharmaceuticals Private LimitedPrevious
Panakeia Drugs And Intermediates PrivatelimitedPrevious

Recent Activity on Solana Life Sciences Private Limited

Solana Life Sciences Private Limited has 11 board changes on record since 2018: 2 appointments and 9 cessations. The latest: Arun Durgaprasad Joshi was appointed as Director on 26 Jun 2019.

AGM
Solana Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 4.19 Cr with Charge ID 101099029 was registered on 22 May 2025.
Filing
Solana Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Axis Bank Limited amounted to Rs. 5.62 Cr with Charge ID 100626457 was registered on 19 Oct 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 5.62 Cr with Charge ID 100626451 was registered on 29 Sep 2022.
Charges
A charge with Axis Bank Limited of Rs. 8.41 Cr registered on 30 Jul 2021 with Charge ID 100467902 was modified on 07 Oct 2021.
Charges
A charge registered on 03 Dec 2020 via Charge ID 100426317 with Others was fully satisfied on 06 Sep 2021.
Charges
A charge registered on 23 Jan 2020 via Charge ID 100331126 with Others was fully satisfied on 06 Sep 2021.
Charges
A charge registered on 23 Jan 2020 via Charge ID 100331123 with Others was fully satisfied on 06 Sep 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 8.41 Cr with Charge ID 100467902 was registered on 30 Jul 2021.
Charges
A charge with Others amounted to Rs. 0.37 Cr with Charge ID 100426317 was registered on 03 Dec 2020.
Charges
A charge with Others of Rs. 3.90 Cr registered on 23 Jan 2020 with Charge ID 100331123 was modified on 16 Oct 2020.

28 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Solana Life Sciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Solana Life Sciences Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Solana Life Sciences Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Solana Life Sciences Private Limited

Solana Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAECA5202F1ZEMadhya PradeshActive09 Oct 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Solana Life Sciences Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solana Life Sciences Private Limited

Solana Life Sciences is an active private limited company based in Dhar, Madhya Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 13 September 1999 (27+ years old) and is registered under CIN U24231MP1999PTC013742.

Solana Life Sciences reported revenue of ₹16.49 Cr for FY 2024 (up 18% YoY).

Solana Life Sciences has 2 current directors:

Solana Life Sciences reported a net profit of ₹10.43 Lakh (net margin 0.6%) and EBITDA of ₹1.58 Cr (EBITDA margin 9.6%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Solana Life Sciences is 26% over three years and 242% over five years. In the latest year (FY 2024) revenue rose 18%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Solana Life Sciences is 23AAECA5202F1ZE, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Solana Life Sciences is U24231MP1999PTC013742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Solana Life Sciences has 2 court cases on record: 2 filed against it.

Solana Life Sciences was incorporated on 13 September 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Solana Life Sciences by revenue are Arkgen Pharma Private Limited, MNR Labs Private Limited, Susaah Laboratories Private Limited, Sai Sreyas Pharmaceutical Private Limited, Rchem Organics (Bangalore) Private Limited and 5 more, all in the Pharma industry (API Manufacturers).

Arun Durgaprasad Joshi was appointed as Director on 26 Jun 2019. Subhash Goverdhandasji Bissa ceased to be Director on 26 Jun 2019. Yash Arun Joshi was appointed as Director on 26 Jun 2019. Solana Life Sciences has 11 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available